← Leaderboards
Vance Fowler
Duke University
$19,614,788
Attributed
$19,614,788
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.7M · FY2009–15$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$19,614,788 · 1
By mechanism
N01$19,614,788 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Henry F Chambers$93,384,193
- Jian Jin$14,335,932
- Vance G Fowler$95,483,666
- G Greg Wang$11,565,583
- John H Sampson$43,413,436
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsProbabilityDesignRegimenDrug ExposureSafety TestingStaphylococcal InfectionsDrug ResistanceTherapeutic EffectivenessAntimicrobial ResistanceAntibioticsTranslational ResearchVancomycinAlgorithmsBloodComparative StudyGenus StaphylococcusInfectionOpen LabelRandomizedSafetyStreamAdult
Grant awards (6)
Targeted Clinical Trials for Antimicrobial Resistance$5,696,248
N01 · FY2015 · AI · contact PI
Targeted Clinical Trials for Antimicrobial Resistance$3,797,027
N01 · FY2014 · AI · contact PI
Targeted Clinical Trials for Antimicrobial Resistance$4,142,615
N01 · FY2013 · AI · contact PI
Targeted Clinical Trials for Antimicrobial Resistance$1,730,876
N01 · FY2012 · AI · contact PI
Targeted Clinical Trials for Antimicrobial Resistance$2,825,675
N01 · FY2011 · AI · contact PI
Targeted Clinical Trials for Antimicrobial Resistance$1,422,347
N01 · FY2009 · AI · contact PI